Friedman Paul A

Director at MDGL; Director at INCY; Director at AUXILIUM PHARMACEUTICALS INC

Sold, on record
$324M
Dollars the filings state
Form 4 sales
24
Latest Jan 9, 2026
Form 144 notices
8
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

3
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 144 notice MDGLNotice
    Aug 12, 2025 2025

    Filed to sell 43,605 shares ($15.2M)

    Friedman Paul A, Director

    10b5-1 plan1.6x usual sizeFiling

  2. 2 Form 4 sale MDGLRoutine
    Aug 12, 2025 same day

    Sold 46,808 shares at $355.31 ($16.6M)

    Friedman Paul A, Director

    10b5-1 planSold 20% of holdings ($83.1M position)187,164 shares left1.7x usual sizeFollows a Form 144Filing

  3. 3 Form 144 notice MDGLNotice
    Aug 13, 2025 +1 day

    Filed to sell 129,172 shares ($46.4M)

    Friedman Paul A, Director

    10b5-1 plan4.5x usual sizeFiling

  4. 4 Form 4 sale MDGLUnusual
    Aug 13, 2025 same day

    Sold 129,172 shares at $370.24 ($47.8M)

    Friedman Paul A, Director

    10b5-1 planSold 40.8% of holdings ($117M position)187,164 shares left4.5x usual sizeFollows a Form 144Filing

  5. 5 Form 144 notice MDGLNotice
    Dec 10, 2025 +119 days

    Filed to sell 49,600 shares ($27.5M)

    Friedman Paul A, Director

    10b5-1 plan1.3x usual sizeFiling

  6. 6 Form 4 sale MDGLRoutine
    Dec 10, 2025 same day

    Sold 24,800 shares at $552.18 ($13.7M)

    Friedman Paul A, Director

    10b5-1 planSold 11.7% of holdings ($117M position)187,164 shares left0.7x usual sizeFollows a Form 144Filing

  7. 7 Form 4 sale MDGLRoutine
    Jan 9, 2026 +30 days

    Sold 24,520 shares at $522.39 ($12.8M)

    Friedman Paul A, Director

    10b5-1 planSold 11.6% of holdings ($111M position)187,164 shares left0.8x usual sizeFollows a Form 144Filing

  8. 8 Form 4 sale MDGLRoutine
    Jan 9, 2026 same day

    Sold 280 shares at $551.24 ($154k)

    Friedman Paul A, Director

    10b5-1 planSold 0.1% of holdings ($103M position)187,164 shares left0x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (32)

Form 144 notices and Form 4 sales by Friedman Paul A
Source
Jan 9, 2026Jan 13, 2026MDGLDirectorForm 4 sale280$154k0.1%RoutineSEC
Jan 9, 2026Jan 13, 2026MDGLDirectorForm 4 sale24,520$12.8M11.6%RoutineSEC
Dec 10, 2025Dec 12, 2025MDGLDirectorForm 4 sale24,800$13.7M11.7%RoutineSEC
Dec 10, 2025Dec 10, 2025MDGLDirectorForm 144 notice49,600$27.5MNoticeSEC
Aug 13, 2025Aug 13, 2025MDGLDirectorForm 4 sale129,172$47.8M40.8%UnusualSEC
Aug 13, 2025Aug 13, 2025MDGLDirectorForm 144 notice129,172$46.4MNoticeSEC
Aug 12, 2025Aug 13, 2025MDGLDirectorForm 4 sale46,808$16.6M20.0%RoutineSEC
Aug 12, 2025Aug 12, 2025MDGLDirectorForm 144 notice43,605$15.2MNoticeSEC
Aug 11, 2025Aug 11, 2025MDGLDirectorForm 144 notice3,203$1.1MNoticeSEC
Jul 18, 2025Jul 22, 2025MDGLDirectorForm 4 sale1,400$490k0.7%RoutineSEC
Jul 18, 2025Jul 18, 2025MDGLDirectorForm 144 notice1,400$488kNoticeSEC
Jul 17, 2025Jul 18, 2025MDGLDirectorForm 4 sale28,876$10.2M13.4%RoutineSEC
Jul 17, 2025Jul 17, 2025MDGLDirectorForm 144 notice2,700$931kNoticeSEC
Jul 16, 2025Jul 16, 2025MDGLDirectorForm 144 notice26,176$8.1MNoticeSEC
Apr 8, 2024Apr 10, 2024MDGLDirectorForm 4 sale26,270$6.5M12.4%RoutineSEC
Apr 5, 2024Apr 5, 2024MDGLDirectorForm 4 sale73,730$18M28.4%RoutineSEC
Apr 3, 2024Apr 3, 2024MDGLDirector, OfficerForm 144 notice100,000$24.4MNoticeSEC
Aug 6, 2019Aug 6, 2019INCYDirectorForm 4 sale100,000$8.3M28.1%UnusualSEC
Jun 11, 2018Jun 12, 2018MDGLChief Executive OfficerForm 4 sale73,526$21.1M10.1%Plan not statedSEC
Nov 16, 2017Nov 20, 2017INCYDirectorForm 4 sale28,507$3M9.6%Plan not statedSEC
Mar 17, 2017Mar 20, 2017INCYDirectorForm 4 sale50,000$7.4M14.4%Plan not statedSEC
Feb 23, 2017Feb 27, 2017INCYDirectorForm 4 sale50,000$6M14.4%Plan not statedSEC
Nov 18, 2015Nov 19, 2015INCYDirectorForm 4 sale225,000$25.6M43.1%UnusualSEC
May 27, 2015May 28, 2015INCYDirectorForm 4 sale196,751$21.1M39.8%UnusualSEC
May 22, 2015May 26, 2015INCYDirectorForm 4 sale102,243$11.1M25.6%UnusualSEC
Feb 13, 2015Feb 18, 2015INCYDirectorForm 4 sale120,000$8.9M28.7%UnusualSEC
Dec 5, 2014Dec 8, 2014AUXILIUM PHARMACEUTICALS INCDirectorForm 4 sale29,689$1M74.1%UnusualSEC
Nov 6, 2014Nov 7, 2014INCYDirectorForm 4 sale185,653$12.6M30.8%UnusualSEC
Feb 20, 2014Feb 21, 2014INCYDirectorForm 4 sale33,354$2.1M7.4%Plan not statedSEC
Feb 19, 2014Feb 19, 2014INCYDirectorForm 4 sale771,182$50.6M64.9%UnusualSEC
Sep 10, 2013Sep 12, 2013INCYChief Executive OfficerForm 4 sale376,789$14.1M49.0%UnusualSEC
May 7, 2012May 8, 2012INCYChief Executive OfficerForm 4 sale225,000$5.1M42.1%UnusualSEC